{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:52:01Z","timestamp":1793850721441,"version":"4.6.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The prevalence of tuberculosis (TB) in elderly populations is increasing, primarily due to age-related comorbidities that affect treatment tolerance and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>This study investigated the incidence and types of adverse drug reactions (ADRs) in aging individuals with active pulmonary TB addressed by first-line anti-TB drugs and to assess their impact on clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on 375 elderly individuals with active pulmonary TB. The incidence and types of ADRs to anti-TB drugs were assessed, and quality of life (QOL) was measured using the WHOQOL-BREF scale both pretreatment and posttreatment. Risk factors for ADRs were examined using univariate and multivariate logistic regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among the study participants, those with congestive heart failure were more common in the 70\u201380 age group, while neurological diseases were more prevalent in those over 80 years old. The overall incidence of ADRs increased with age, peaking at 56.76% in individuals aged 80 and older. The most common ADRs included gastrointestinal, neurological, and dermatological reactions. Advanced age, male sex, respiratory failure, and higher rifampicin dosages were identified as significant risk factors for ADRs. Although posttreatment QOL improved across all age groups, the improvement was less pronounced in the oldest group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In elderly TB patients, factors, such as age, sex, respiratory failure, and drug dosage, significantly influence the incidence of ADRs. Tailored treatment strategies and enhanced monitoring are essential to optimize treatment outcomes and improve QOL in this vulnerable population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_745_24","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T14:00:10Z","timestamp":1764424810000},"page":"1305-1313","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Adverse Reactions and Clinical Outcomes of First-line Antituberculosis Drugs in Elderly Patients with Tuberculosis"],"prefix":"10.4103","volume":"28","author":[{"given":"L","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Tuberculosis, Affiliated Hospital of Putian University, Putian, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, Affiliated Hospital of Putian University, Putian, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, Affiliated Hospital of Putian University, Putian, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, Affiliated Hospital of Putian University, Putian, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Putian University, Putian, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"1254579","DOI":"10.3389\/fpubh.2023.1254579","article-title":"Regional and epidemiological characteristics of tuberculosis and treatment outcomes in West China","volume":"11","author":"Wang","year":"2023","journal-title":"Front Public Health"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s40266-021-00880-4","article-title":"Pulmonary tuberculosis in older adults: Increased mortality related to tuberculosis within two months of treatment initiation","volume":"38","author":"Hase","year":"2021","journal-title":"Drugs Aging"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/pds.5513","article-title":"Incidence and outcomes of adverse drug reactions to first-line anti-tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study","volume":"31","author":"Choi","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.3390\/jcm10245888","article-title":"Tuberculosis in the elderly","volume":"10","author":"Caraux-Paz","year":"2021","journal-title":"J Clin Med"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/ggi.13844","article-title":"Risk factors for adverse drug reactions in older inpatients of geriatric wards at admission: Multicenter study","volume":"20","author":"Kojima","year":"2020","journal-title":"Geriatr Gerontol Int"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"2313683","DOI":"10.1080\/07853890.2024.2313683","article-title":"Tuberculosis (TB) treatment challenges in TB-diabetes comorbid patients: A systematic review and meta-analysis","volume":"56","author":"Khattak","year":"2024","journal-title":"Ann Med"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijtb.2020.01.008","article-title":"Tuberculosis and risk of coronary heart disease: A systematic review and meta-analysis","volume":"67","author":"Wongtrakul","year":"2020","journal-title":"Indian J Tuberc"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1017\/S0950268817000152","article-title":"Determinants of mortality in elderly patients with tuberculosis: A population-based follow-up study","volume":"145","author":"Yen","year":"2017","journal-title":"Epidemiol Infect"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/cid\/ciz306","article-title":"Tuberculosis in older adults: Seattle and King County, Washington","volume":"70","author":"Gardner Toren","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12879-023-08183-2","article-title":"Impaired pulmonary function and associated factors in the elderly with tuberculosis on admission: A preliminary report","volume":"23","author":"He","year":"2023","journal-title":"BMC Infect Dis"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40545-023-00577-6","article-title":"Determinants of adverse reactions to first-line antitubercular medicines: A prospective cohort study","volume":"16","author":"Djochie","year":"2023","journal-title":"J Pharm Policy Pract"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2147\/IJGM.S258953","article-title":"Comparison of SF-36 and WHOQoL-BREF in measuring quality of life in patients with type 2 diabetes","volume":"13","author":"Abbasi-Ghahramanloo","year":"2020","journal-title":"Int J Gen Med"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1038\/s41598-023-33967-6","article-title":"Factors associated with adverse drug reactions or death in very elderly hospitalized patients with pulmonary tuberculosis","volume":"13","author":"Yagi","year":"2023","journal-title":"Sci Rep"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s15010-019-01324-3","article-title":"Incidence of adverse reactions caused by first-line anti-tuberculosis drugs and treatment outcome of pulmonary tuberculosis patients in Morocco","volume":"48","author":"El Hamdouni","year":"2020","journal-title":"Infection"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/antibiotics9080489","article-title":"Active pulmonary tuberculosis in elderly patients: A 2016-2019 retrospective analysis from an italian referral hospital","volume":"9","author":"Di Gennaro","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/crj.12242","article-title":"Clinical features and treatment of drug fever caused by anti-tuberculosis drugs","volume":"10","author":"Fang","year":"2016","journal-title":"Clin Respir J"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"e38273","DOI":"10.1097\/MD.0000000000038273","article-title":"Evaluation of adverse reactions induced by anti-tuberculosis drugs among hospitalized patients in Wuhan, China: A retrospective study","volume":"103","author":"Shi","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"e533","DOI":"10.1097\/MJT.0000000000000421","article-title":"Occurrence, management, and risk factors for adverse drug reactions in multidrug resistant tuberculosis patients","volume":"25","author":"Ahmad","year":"2018","journal-title":"Am J Ther"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"e0236109","DOI":"10.1371\/journal.pone.0236109","article-title":"The high incidence of severe adverse events due to pyrazinamide in elderly patients with tuberculosis","volume":"15","author":"Kwon","year":"2020","journal-title":"PLoS One"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1038\/s41598-021-86994-6","article-title":"Spatial distribution and risk factors of adverse treatment outcomes of tuberculosis in Guizhou, China, 2013\u20132018","volume":"11","author":"Zhou","year":"2021","journal-title":"Sci Rep"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"122","DOI":"10.34172\/aim.2024.19","article-title":"Managing hepatotoxicity caused by anti-tuberculosis drugs: A comparative study of approaches","volume":"27","author":"Abbaspour","year":"2024","journal-title":"Arch Iran Med"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/apc.2017.0116","article-title":"Substantially higher and earlier occurrence of anti-tuberculosis drug-related adverse reactions in HIV coinfected tuberculosis patients: A matched-cohort study","volume":"31","author":"Matono","year":"2017","journal-title":"AIDS Patient Care STDS"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4103\/njcp.njcp_689_20","article-title":"Psychological distress and health-related quality of life among stable patients with bronchiectasis","volume":"25","author":"Umoh","year":"2022","journal-title":"Niger J Clin Pract"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12913-023-09381-z","article-title":"Survey to measure the quality of life of patients with tuberculosis in Alexandria, Egypt: A cross-sectional study","volume":"23","author":"Hammouda","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"R25-20260420","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/ijoy.ijoy_208_23","article-title":"Effect of yoga on quality of life in patients with pulmonary tuberculosis: A randomized control trial","volume":"16","author":"Srinivas","year":"2023","journal-title":"Int J Yoga"},{"key":"R26-20260420","doi-asserted-by":"crossref","first-page":"790134","DOI":"10.3389\/fcimb.2022.790134","article-title":"Prospective evaluation of positivity rates of aspergillus-specific IgG and quality of life in HIV-negative tuberculosis patients in Lagos, Nigeria","volume":"12","author":"Oladele","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R27-20260420","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1039\/C9FO01583C","article-title":"Efficacy of proprietary Lactobacillus casei for anti-tuberculosis associated gastrointestinal adverse reactions in adult patients: A randomized, open-label, dose-response trial","volume":"11","author":"Lin","year":"2020","journal-title":"Food Funct"},{"key":"R28-20260420","doi-asserted-by":"crossref","first-page":"e1252","DOI":"10.1093\/cid\/ciab209","article-title":"Completion rate and safety of programmatic screening and treatment for latent tuberculosis infection in elderly patients with poorly controlled diabetic mellitus: A prospective multicenter study","volume":"73","author":"Huang","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R29-20260420","doi-asserted-by":"crossref","first-page":"621","DOI":"10.5588\/ijtld.14.0996","article-title":"Adverse drug reactions in tuberculosis patients: Consequences for TB control","volume":"19","author":"Naik","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"R30-20260420","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jcrc.2018.03.015","article-title":"The critically ill patient with tuberculosis in intensive care: Clinical presentations, management and infection control","volume":"45","author":"Otu","year":"2018","journal-title":"J Crit Care"},{"key":"R31-20260420","doi-asserted-by":"crossref","first-page":"2000955","DOI":"10.1183\/13993003.00955-2020","article-title":"Increased bactericidal activity but dose-limiting intolerability at 50 mg.kg(-1) rifampicin","volume":"58","author":"Te Brake","year":"2021","journal-title":"Eur Respir J"},{"key":"R32-20260420","doi-asserted-by":"crossref","first-page":"822201","DOI":"10.3389\/fmed.2022.822201","article-title":"Intensified antituberculosis therapy regimen containing higher dose rifampin for tuberculous meningitis: A systematic review and meta-analysis","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Med (Lausanne)"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_745_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:48:42Z","timestamp":1787068122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_745_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_745_24","relation":{},"ISSN":["1119-3077","2229-7731"],"issn-type":[{"value":"1119-3077","type":"print"},{"value":"2229-7731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"2024-10-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}